Adverse cardiovascular complications following prescription of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors
Jiandong Zhou, View ORCID ProfileGary Tse, Xiansong Wang, Ishan Lakhani, Sharen Lee, Lei Yang, Tong Liu, Yunlong Xia, Esther W Chan, Ian Chi Kei Wong, William KK Wu, Qingpeng Zhang
doi: https://doi.org/10.1101/2020.12.21.20248648
Jiandong Zhou
1School of Data Science, City University of Hong Kong, Hong Kong, China
Gary Tse
2Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
3Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China
MD FRCP FACCXiansong Wang
4Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
MPhilIshan Lakhani
3Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China
Sharen Lee
3Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China
Lei Yang
2Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
MD PhDTong Liu
2Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
MD PhDYunlong Xia
5Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China
MD PhD FACCEsther W Chan
6Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong, China
PhDIan Chi Kei Wong
6Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong, China
PhDWilliam KK Wu
4Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
PhD FRCPathQingpeng Zhang
1School of Data Science, City University of Hong Kong, Hong Kong, China
PhDArticle usage
Posted December 22, 2020.
Adverse cardiovascular complications following prescription of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors
Jiandong Zhou, Gary Tse, Xiansong Wang, Ishan Lakhani, Sharen Lee, Lei Yang, Tong Liu, Yunlong Xia, Esther W Chan, Ian Chi Kei Wong, William KK Wu, Qingpeng Zhang
medRxiv 2020.12.21.20248648; doi: https://doi.org/10.1101/2020.12.21.20248648
Adverse cardiovascular complications following prescription of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors
Jiandong Zhou, Gary Tse, Xiansong Wang, Ishan Lakhani, Sharen Lee, Lei Yang, Tong Liu, Yunlong Xia, Esther W Chan, Ian Chi Kei Wong, William KK Wu, Qingpeng Zhang
medRxiv 2020.12.21.20248648; doi: https://doi.org/10.1101/2020.12.21.20248648
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4158)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2694)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2071)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (461)
- Public and Global Health (6578)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)